Streptococcus agalactiae hyaluronate lyase is a virulence factor that helps this pathogen to break through the biophysical barrier of the host tissues by the enzymatic degradation of hyaluronan and certain chondroitin sulfates at ␤-1,4 glycosidic linkages. Crystal structures of the native enzyme and the enzyme-product complex were determined at 2.1-and 2. 
Streptococcus agalactiae (group B streptococci, GBS) 1 is the predominant cause of meningitis and septicemia in humans, often leading to the death in neonates (1, 2) . The knowledge about the molecular basis that leads to the development of these invasive diseases is still limited. Several putative pathogenic factors were identified, including the polysaccharide capsule, hemolysin, C5a peptidase, C-proteins, and hyaluronate lyase (3) . High levels of hyaluronate lyase (SagHL) were found in the extracellular cultures of the disease-causing strains of serotype III GBS (4 -6) . Clinical studies indicated that strains of type III GBS that produce more extracellular hyaluronate lyase (division I S. agalactiae) are apparently more virulent than those strains producing less (division II S. agalactiae) (5, 6) . Division I S. agalactiae usually causes invasive infections, whereas division II bacteria cause diseases much less frequently and are usually found in asymptotically colonized infants. The molecular function of SagHL is to degrade hyaluronan (HA) and certain chondroitin sulfates (CS). The enzymatic degradation of these polysaccharides breaks down the biophysical barrier of the host connective tissues, therefore facilitating the invasion and spreading of this pathogen.
Structurally, HA is a high molecular weight polysaccharide built by linear repeats of disaccharide units, (␤-1,4-D-glucuronic acid-␤-1,3-N-acetyl-␤-D-glucosamine) n . It is produced by almost all members of the animal kingdom, as well as by certain members of Streptococci (7), and is widely distributed in various connective tissues and the nervous system. The human tissues known to contain HA include synovial fluid, the vitreous humor of the eye, umbilical tissue, amniotic fluid, aorta, leukocytes, plasma, blood platelets, brain, articular cartilage, liver, prostate, skin, teeth, and urine (8) . Through inter-and intramolecular interactions, HA forms strikingly viscous solution, which provides not only a soft and elastic "bed" for tissue cells to grow on, but also a medium for the intercellular communication. Various kinds of cell surface receptors are secreted into the extracellular matrix for the purpose of communication between cells. Many of them, such as CD44 and RHAMM, are known to bind to HA (9) and be involved in signal transduction processes.
Bacteria usually secretes hyaluronate lyases for the purpose of HA degradation, and the enzyme produces unsaturated products, whereas animals employ hyaluronidases, a group of hydrolases, for the HA degradation without unsaturation of the products (10) . Various Gram-positive microorganisms including species of Streptococcus, Clostridium, Propionibacterium, Peptostreptococcus, and Streptomyces produce hyaluronate lyase (11) . All known bacterial hyaluronate lyases were found to share substantial sequence identity and thus likely to use the similar mechanism for the catalytic action (12) .
The degradation of HA by bacterial hyaluronate lyases occurs at the ␤-1,4 glycosidic linkage between disaccharide units and produces C4 -C5 double bond on the glucuronic residue of its products. The mechanism of the unsaturation in the HA degradation was recently revealed (12) . This depolymerization of HA in vivo causes the destruction of the intracellular matrix and exposes the host cells to various bacterial toxins (13) . Significant additive attenuation in virulence was observed for streptococci with hyaluronate lyase and pneumolysin double mutations (13) . Therefore, the HA degradation is an important step in bacterial invasion and spreading. Because sequences and the mechanisms of HA degradation are different for bacteria and animals, it suggests that these two group of enzymes are significantly different. Therefore, hyaluronate lyase may be targeted to inhibit bacterial invasion (14) .
As part of our effort to elucidate the molecular basis of action of this enzyme, S. agalactiae hyaluronate lyase (SagHL) was overexpressed, purified, and crystallized as reported previously (15) (16) (17) . Here we present the SagHL native crystal structure at 2.1-Å resolution and a complex structure with the 4,5-unsaturated disaccharide, the degradation product of this enzyme, at 2.2-Å resolution. The complete active site residues were identified. The mechanisms of HA and CS degradation were proposed based on the x-ray crystallography studies of SagHL native and disaccharide complex structures, the substrate binding modeling studies, and the known mutations of the active site residues (18) . The structure basis of substrate binding, cleavage site selection, substrate degradation, product unsaturation and release, product size determination, and the direction of HA chain processive degradation are discussed.
EXPERIMENTAL PROCEDURES
SagHL Structure Determination-SagHL expression (gene hylB 3502 ), purification, crystallization, and data collection have been reported previously (16) . SagHL crystal structure was determined at 2.1-Å resolution by the molecular replacement (MR) method using a poly(A)LA model derived from the S. pneumoniae hyaluronate lyase (SpnHL) crystal structure (12) . The sequence homology of SagHL to SpnHL is 53%. MR calculation was performed using the program AMoRe (19) . The two domains of the SpnHL structure (␣-domain and the ␤-domains) were treated as two separate molecules. The MR calculation provided one solution that was about 10 times higher than the other peaks. No implausible structural conflicts were observed among symmetry-related molecules on graphics. The initial R factor was 0.502 and R free 0.497. The SagHL enzyme has additional 82 residues at the N terminus and six places of insertions as compared with the SpnHL enzyme. The insertions were treated as chain breaks in the next step of the model building on graphics using program O (20) . The structural refinement was performed using program X-PLOR (21) against 53,312 reflections at 50.0 -2.1-Å resolution range. The R free flag was assigned to 2% (1,074) reflections for the validation of the refinement progress. The inserted residues, side chains, and the N terminus were built gradually on graphics using O (20) between each round of refinement until the R factor dropped to 0.282 and R free to 0.340. Then, the B-factor refinement was introduced and waters were added following standard criteria. Statistics for the SagHL crystal data collection and structural refinement were summarized in Table I .
, was obtained as described previously (17) . Native SagHL crystals were soaked with 50 mM ⌬Di-HA for elongated period of time. The crystals were cryoprotected using the same condition as for the native crystals (16) , and the diffraction data set at 2.2-Å resolution was collected. The diffraction data were processed using the HKL2000 package (22) with R sys of 0.101 and the completeness of 98.1%. The native SagHL structure without water molecules was used as the initial model for the complex structure determination and refinement using program X-PLOR protocols (21) . The structure was manually fitted on graphics using program O (20) , and was refined against 45,510 reflections at 50 -2.2-Å resolution range. Only 2% (860) reflections were randomly selected and assigned R free flags for monitoring and validation of the progress of the structural refinement. Two ⌬Di-HA molecules and 256 waters were incorporated into the final structure model.
Modeling of Tetrasaccharide into the Active Site-The model of tetrasaccharide bound in the active site of SagHL was obtained to investigate binding of longer HA substrates in the active site cleft of the enzyme. The tetrasaccharide coordinates were taken from the crystal structure of SagHL disaccharide HA complex consisting of two disaccharide units, HA1 and HA2 (see below). The HA1 disaccharide molecule was kept unmoved, whereas the HA2 disaccharide was rotated and moved to form a linear tetrasaccharide with HA1. Then, the coordinates of the derived tetrasaccharide were optimized against the protein part using energy dynamic minimization in X-PLOR (21) with the protein coordinates fixed initially and released in the second round of the refinements.
RESULTS AND DISCUSSION
Activation of SagHL-The native SagHL undergoes extensive proteolysis after its synthesis, resulting in a mixture of at least three molecular mass products: 118, 111, and 92 kDa (18, 23) . The 118-kDa form is enzymatically inactive and the 111-and 92-kDa forms are active (18) . It suggests that SagHL is synthesized as an inactive 118-kDa form inside the bacteria (23) . When the enzyme is secreted into the extracellular matrix, it is activated by the cutting off of the signal segment at the N terminus, leaving an active 111-kDa form (23) . The enzyme is then further degraded into a more stable 92-kDa form (16) . This last process is likely to be caused by autodegradation in the presence of calcium ions (16) . The SagHL structure determination work was performed on the autodegradation product of hylB 3502 , which is the 92-kDa form of SagHL, (16) .
Overall Structure-All 814 residues were modeled in the 2.1-Å resolution SagHL crystal structure. A total of 538 waters were incorporated into the final SagHL model. The final R cryst is 0.191 and R free 0.253. In the final structure, 99.6% of the residues fall in the energetically favored regions in the Ramachandran plot (24) . Two residues, Thr 480 and Asn 769 , are in disallowed regions. Both residues are located on the surface loop regions, and their electron densities are plausible. The side chains of Glu 468 and Tyr 635 form several hydrogen bonds with the main chain atoms of these two residues, respectively. These interactions likely displace Thr 480 and Asn 769 to the energetically unfavorable regions.
The SagHL crystal structure is constructed from three structural domains (Fig. 1A) , the N-terminal ␤-sheet domain (␤I-domain, containing residues from Ala 171 to Val 244 ), the middle ␣-helical domain (␣-domain, residues from Phe 252 to Asn 611 ), and the C-terminal ␤-sheet domain (␤II-domain, residues from Lys 621 to Ile 984 ). Two peptide linkers connect these three domains. Linker I (residues from Thr 245 to Asn 251 ) connects the ␤I-domain and the ␣-domain, and linker II (residues from Asp 612 to Leu 620 ) connects the ␣-domain and the ␤II-domain. The ␣-domain is primarily composed of 13 ␣-helices that are named sequentially from helix 1 to helix 13 from the N terminus to the C terminus (Fig. 1B) . Ten of them (helix 3 to helix 12) are arranged into an incomplete ␣ 5 /␣ 5 barrel structure, and helix 2 and helix 13 are in the position of blocking the incomplete barrel opening. The two ends of this barrel structure are not of the same size. The larger end encompasses the predominant cleft, which is located between the ␣-and the ␤II-domains. The smaller end is blocked by helix 1. The N-terminal ␤I-domain is primarily composed of seven ␤-strands arranged into two anti-parallel ␤-sheets. The C-terminal ␤II-domain is mainly composed of 25 ␤-strands arranged into five anti-parallel ␤-sheets.
The orientation of the N-terminal segment from Ser 171 to Glu 182 extends out of the ␤I-domain along the surface of the ␣-domain toward the cleft region (Fig. 1A) . Such orientation of this segment of the enzyme suggests that this part might be a linker to yet another structural domain at the N terminus. It is possible that the unknown part of the structure, the first 212 residues in the sequence of SagHL at the N terminus, might form at least one structural domain near the cleft region. The function of the ␤I-domain is still unclear, but it might possibly serve as a connection of the catalytic ␣-domain (see below) to this unknown structural domain.
The cleft in the ␣-domain of SagHL is located in the middle of the SagHL structure, close to the interface between the ␣-domain and the ␤II-domain (Fig. 1 ). The dimensions of this cleft are about 30 Å in length, 10 Å in width, and 10 Å in depth. A total of 28 charged residues, 22 from the ␣-domain and 6 from the ␤II-domain, are accumulated along the edges of the cleft. Most of these residues are positively charged, including 10 lysines and 9 arginines. These charged residues are distributed along both sides and the bottom of the cleft and likely contribute to the attraction and binding of the negatively charged, tape-shaped substrates, HA or CS. This charged region of the enzyme is by far its most positively charged segment overall.
SagHL-⌬Di-HA Complex Structure and Substrate Binding-To confirm that the cleft is the place where the substrate/ product bind to pursue the enzymatic action catalyzed by SagHL, the product of this enzyme, 4,5-unsaturated disaccharide, ⌬Di-HA, was soaked into the SagHL crystal. The refined structure of native SagHL without water molecules was used as primary model for the SagHL-⌬Di-HA complex structure solution and refinements against 45,510 reflections. The final R cryst was 0.182, and the R free was 0.254; 332 water molecules were incorporated into the electron density as described under "Experimental Procedures."
The protein part of the complex structure is similar to the native SagHL structure with the root mean square deviation of 0.89 Å. Similarly to the native enzyme, it consists of three structural domains: ␤I, ␣, and ␤II. The orientation of the residues in the cleft is virtually the same as in the native enzyme structure. The structure of HA substrate has two distinct features that facilitate its binding to the enzyme cleft. One is the negative charges due to the carboxylate groups along the HA chain, and the hydrophobic patches generated by the sugar rings of the tape-shaped HA chain. The arrangement of these hydrophobic patches is ambidextrous (25) . Two ⌬Di-HA mole- FIG. 1 . A, the ribbon diagram of the structure of S. agalactiae hyaluronate lyase. The termini, the ␤I-domain, linkers, the ␣-domain, the ␤II-domain, and the positions of the cleft and two ⌬Di-HA molecules in the active site are shown. B, stereo view of the ribbon diagram of the catalytic ␣-domain. The relative positions of 13 helices in the ␣-domain are shown. The incomplete ␣5/␣5 barrel structure constructed by H3 to H12 helices can be identified. The cleft is located above in the front of the figure and transverses the molecule horizontally. ⌬Di-HA molecules are presented to mark the position of HA1 and HA2 in this direction of view. The residues are numbered every 100 amino acids. ␣-Helices are blue, ␤-strands green, turns dark blue, and coils yellow. Two ⌬Di-HA molecules are shown in green. The figure was made using Ribbons software (40) .
cules were observed binding to the cleft region in the SagHL⌬Di-HA complex structure and were named as the HA1 and HA2 position ⌬Di-HA, respectively (Fig. 2) . HA1 is in contact with six protein residues from the ␣-domain only (Fig. 3A) , and HA2 is in contact with another group of six residues from both the ␣-and the ␤II-domains (Fig. 3B) . Enzyme residues interacting with these two ⌬Di-HA molecules and the hydrogen bonds at their interfaces were listed in Table II . As expected, the sugar rings of the N-acetyl-␤-D-glucosamines of HA1 and HA2 are in a chair conformation, whereas the sugar rings of the unsaturated ␤-D-glucoronate are in a half-chair conformation. The SagHL-⌬Di-HA complex structure confirmed that the cleft is the region where the substrates are bound and degraded.
Modeling of the Substrate Binding and the Active Site Identification-The two ⌬Di-HA molecules, HA1 and HA2, observed in the SagHL-⌬Di-HA complex structure were not connected together as it would be in the case of a tetrasaccharide, although their positions are close to such arrangement. To analyze more precisely the substrate binding pattern, a tetrasaccharide hyaluronan was modeled into the HA binding cleft of the enzyme based on the two ⌬Di-HA positions in the SagHL⌬Di-HA complex structure (HA1 and HA2; as described under "Experimental Procedures") (Fig. 4) . The two-disaccharide building blocks of the tetrasaccharide were also named HA1 and HA2 because the displacement from their corresponding positions in the complex structure is small. HA1 is located at the reducing end of the HA substrate chain, and HA2 is at the nonreducing end. HA1 disaccharide was almost unmoved, and the HA2 disaccharide needed to be slightly rotated to obtain the tetrasaccharide arrangement. HA2 was rotated so that the N-acetamino-2-deoxy-D-glucose residue of HA2 is facing the D-glucuronic acid residue of HA1 and to allow for the ␤-1,4
FIG. 2. Electron density maps for two ⌬Di-HA molecules in the SagHL-⌬Di-HA complex structure. The figure was made using O (20) and Ribbons software (40) . The figure shows the 2F o Ϫ 1F c electron density maps at 1 level for HA1 ⌬Di-HA (A) and HA2 ⌬Di-HA (B).
glycosidic with HA1. In the complex structure, 4 arginine residues (Table II) modify the orientation of the electronegative HA2 ⌬Di-HA away from the position of alignment along the cleft to a new rotated orientation (Fig. 3B) . There are four possible ways to fit the tetrasaccharide into the cleft. The tetrasaccharide position in the cleft can be end-flipped (the reducing versus the nonreducing end) or side-flipped (the inner versus the outer side of the cleft). Tetrasaccharide in Fig. 4 has no bad interactions with the enzyme residues in the cleft, and the positions of two ⌬Di-HA molecules in the complex need the least movement to obtain this arrangement, whereas in any other three positions, tetrasaccharide has significant number a The numbers in parentheses show the number of contacts that particular residue made with ⌬Di-HA molecules. Atom pairs within 4.1 Å were considered to be in contact.
b These selected distances were also marked using dotted lines on Fig. 3 (A and B) . c UA1 and UA2 denote the unsaturated analog for ␤-D-glucuronic acid of HA1 and HA2, whereas NAc1 and NAc2 denote N-acetyl-␤-Dglucosamine of HA1 and HA2, respectively.
d The symbols assigned to atoms of the disaccharide product follow standard chemical nomenclature.
of bad interactions with the residues of the cleft. The interactions were considered too close (or bad) when any two-atom pairs between the modeled substrate and the enzyme were in a distance of 2. Although not in the above list, His 479 was the initial residue identified earlier by site-directed mutagenesis studies as a possible catalytic residue in SagHL (16, 26) . In the SagHL crystal structure, this residue is located at the bottom of the cleft. In the tetrasaccharide complex model, the NH 2 side chain atom of His 479 was pointing toward the C5 atom of the HA1 glucuronate sugar residue (Fig. 4) . Site-directed mutagenesis studies of SagHL performed by Pritchard et al. (26) showed that single mutations of N429A, H479G, H479A, Y488F, Y488T, and Y488L inactivated the enzyme completely. It suggested their possible involvement in the enzyme catalysis. Based on the mutations and the native structure, the disaccharide complex structure, and the tetrasaccharide substrate model, the active site residues can be classified into two parts: Trp 371 , Trp 372 , and Phe 423 forming a hydrophobic patch, and His 479 , Tyr 488 , and Asn 429 forming a catalytic group. Their proposed function in the degradation of HA and CS will be discussed in detail in the following section. The relative positions of these residues with respect to the tetrasaccharide substrate are shown in Fig. 4 .
Proposed Mechanism of Hyaluronan Degradation-Based on the SagHL native, the product complex structures, the modeled tetrasaccharide complex, the site-directed mutagenesis studies (26) , and our previous studies on SpnHL (12) , the enzymatic HA degradation by SagHL can be postulated as the following five successive steps (Fig. 5) . First, the positively charged cleft of the enzyme attracts the anionic HA substrate chain and binds to it. In the second step, the aromatic patch of the enzyme composed of Trp 371 , Trp 372 , and Phe 423 accurately anchors and positions the tape-shaped, ambidextrous substrate chain into the correct degradation position. At this stage the side chain of Trp 372 is likely parallel to the hydrophobic patch on the Nacetylglucosamine residue of the HA2 disaccharide unit and the side chain of Phe 423 is parallel to the hydrophobic patch on the glucuronic residue of the HA1 disaccharide unit, which stabilizes and positions these two disaccharide units in the precise position in the cleft. Such interactions between the polysaccharide chain and the aromatic residues are widely seen in protein-carbohydrate complexes (27) . In this way, the ␤1,4 glycosidic linkage cleavage site on the bound in the cleft HA chain is properly positioned and selected for degradation. At this position, the carboxylate group of the HA1 glucuronate group is oriented toward the side chain of catalytic residue Asn 429 . The glycosidic oxygen O4 points toward the O atom of Tyr 488 , and the C5 of the HA1 glucuronate points toward His 479 . The side chain of Asn 429 forms a couple of hydrogen bonds with the carboxylate group of the HA1 glucuronic moiety of HA, attracting the negative charges on the carboxylate group away from C5 and resulting in a relatively acidic C5 hydrogen. In the third step, this C5 atom loses a proton that is withdrawn by His 479 , resulting in the rehybridization of the C5 carbon from sp 3 to sp 2 . In the fourth step, at the same time as His479 withdraws one proton from HA1 glucuronic C5, Tyr 488 , located at the bottom of the cleft and interacting with the O4 oxygen atom of the glycosidic linkage, donates a proton to this glycosidic oxygen (O4) and breaks the glycosidic linkage. HA1 glucuronic C4 is thus rehybridized from sp 3 to sp 2 similarly to the C5 carbon. Therefore, a double bond is formed between the two (C4 and C5) sp 2 hybridized carbon atoms of the HA1 disaccharide, which accomplished the unsaturation of the product. We observed that, among the dominating positively charged residues in the cleft, there are also three negatively charged residues, Glu 468 , Asp 478 , and Thr 480 , clustered together at the HA1 position, opposite to Phe 423 . These three residues form a negative patch (Fig. 6) . After the covalent glycosidic linkage is broken, this negative patch is likely responsible for repelling the negatively charged products out of the cleft (product release). In the fifth and the final step, His 479 loses its acquired proton and Tyr 488 attracts a proton probably from the surrounding water molecules; thus, the enzyme returns to its original state and is ready for the next round of catalysis. We described this mechanism as proton acceptance and donation (PAD).
In this mechanism, the above five steps are equally important in the substrate degradation. In total, the protein accepts one proton from the substrate and donates one proton to the substrate to complete the degradation. The protein acts as a proton exchanger, mediating a pair of proton exchange between waters and the HA substrate, resulting in the degradation of the substrate, and the unsaturation of the product. In our structure of the enzyme complex with the degradation product, an unsaturated disaccharide unit of HA, we are able to identify the product to be released because of a very high concentration of this molecule during the soaking process in the crystals and very long soaking time (50 mM for 3 months; see "Experimental Procedures"). Under physiological conditions, the concentration of the product is much lower, allowing for its release as described above.
Recent structural studies of degradation of dermatan sulfate by chondroitinase AC lyase (28) and alginate by alginate lyase (29) suggest slightly different mechanisms of action of these two enzymes. For the chondroitinase AC lyase, in addition to essentially the PAD mechanism, a catalytic Tyr residue (Tyr 234 ) was suggested to act as both, general base and acid. Although possible, our studies do not confirm such possibility for SagHL. In addition, the involvement of an Arg residue (Arg 288 ) was suggested as a general acid. For SagHL, the role of a homologous Arg residue is only to stabilize the environment of the catalytic site, primarily around Asn 429 . Finally, for alginate lyase it is suggested that both an Asn residue (Asn 191 ) and the neighboring Arg residue (Arg 239 ) act together as electron sink for the alginate's carboxyl group. Additionally, the role of Tyr 246 was suggested to be both general acid and base. Such mechanism seems plausible for the alginate lyase enzyme; our studies do not confirm the direct involvement of a homologous Arg residue in catalysis for SagHL as well as the acid/base role of the Tyr residue.
Substrate Binding in the Catalytic Cleft-Based on the products produced, bacterial hyaluronate lyases can be divided into two groups. Group I enzymes degrade HA into unsaturated disaccharide only, whereas group II enzymes degrade HA into unsaturated oligosaccharides, usually tetra-or hexasaccharides, or a mixture of the two (30) . SagHL produces unsaturated disaccharide units only (16, 18) and is, therefore, a member of the group I enzymes. An example of group II enzyme is the Streptomyces hyalurolyticus hyaluronate lyase, which was shown to produce a mixture of tetra-or hexasaccharides (30) .
The three catalytic residues, Asn 429 , His 479 , and Tyr 488 in SagHL are conserved among all known bacterial hyaluronate lyases, but the aromatic patch residues (Trp 371 , Trp 372 , and Phe 423 ) are only partly conserved (Fig. 7) . The two neighboring tryptophan residues of the patch, Trp 371 and Trp 372 in SagHL, are uniformly conserved whereas Phe 423 is only conserved in group I lyases such as SpnHL and SagHL, not in group II enzymes (Fig. 7) . In the mechanism proposed above, the aromatic patch is important in the selection of cleavage site on the substrate chain. Through hydrophobic interactions, the two tryptophan residues anchor the HA2 disaccharide unit and Phe 423 anchors the HA1 disaccharide position through their hydrophobic interactions, whereas the glycosidic linkage between HA1 and HA2 is being degraded (Fig. 4) . Single mutations of either of the two neighboring tryptophan residues did not significantly affect the enzyme activity, whereas double mutation W371F/W372V completely eliminated the enzyme activity (26) . The two tryptophan residues together are likely predominantly responsible for the binding and positioning of the HA2 disaccharide unit. However, without Phe 423 , the substrate cannot be properly positioned at the HA1 position, and, therefore, the substrate most likely cannot be degraded. The binding of the substrate at the HA3 position in the cleft is different among group II enzymes. There are no aromatic residues around the HA3 position, and there are no hydrophobic interactions involved in the HA3 disaccharide binding. Ionic interactions and hydrogen bonds that are different from the HA1 and HA2 disaccharide binding mainly bind the HA3 disaccharide. In summary, the phenylalanine residue corresponding to Phe 423 in SagHL in group I bacterial lyases stabilizes and positions the HA1 disaccharide in the active site.
Action Pattern-The difference in the aromatic patch composition between group I and group II bacterial hyaluronate lyases may also explain their different action patterns. The physiological molecular weight of HA is usually several million daltons (7) . One HA chain may contain a few hundred to over 5,000 disaccharide units. Bacterial hyaluronate lyases may act on the HA chain in two different patterns of degradation, either in a processive or nonprocessive way (31, 32) . In a nonprocessive degradation pattern, the enzyme leaves the substrate chain after the first degradation, then binds randomly to another cleavage site on the same or different substrate chain. In a processive degradation pattern, the enzyme binds to a cleavage site of the polymeric substrate chain, degrades it and FIG. 6. Electrostatic potential distribution in the catalytic cleft. The cleft is placed in the same orientation as in Figs. 1-4 . The positive potential is shown in blue and negative potential in red. Majority of the cleft is highly positively charged, whereas at the productreleasing end of the cleft (HA1 position) a negative patch is clearly present as labeled. The position of the hydrophobic patch is also labeled. The figure was made using Grasp (41) . moves along the substrate chain continually until the whole chain is degraded.
Biochemical studies of the hyaluronan degradation and product analysis showed that the action pattern of the group I enzyme SagHL is processive and produces disaccharide only (32) . In contrast, the action pattern of the group II enzyme, for example, S. hyalurolyticus hyaluronate lyase, is nonprocessive and produces a mixture of tetra-and hexasaccharides (31) . Among the active site residues, the difference between these two groups of bacterial hyaluronate lyases is in the phenylalanine residue of the aromatic patch. In group I bacterial hyaluronate lyases, after the initial degradation is accomplished and the product is released, HA1 position is emptied. Phe 423 immediately attracts the next HA unit into the degradation position through hydrophobic interactions between the phenyl group of Phe 423 and the next disaccharide unit of the HA substrate chain before the remaining substrate chain can leave the cleft. Through this hydrophobic matching, the next disaccharide unit is accurately anchored into the HA1 position for the next round of substrate degradation process. Because the HA substrate chain is moved by one disaccharide unit at each time, only ⌬Di-HA is produced. Additionally, the enzyme action pattern is processive. In group II bacterial hyaluronate lyases, without this phenylalanine, the hydrophobic stability force provided by the side chain of phenylalanine is missing, the remaining substrate chain leaves the cleft, and the enzyme randomly chooses and binds to another cleavage site on the substrate chain. In this case, the enzyme action pattern will be nonprocessive as in the group II bacterial hyaluronate lyases.
Direction of Hyaluronan Chain Degradation-SagHL degrades HA in the processive pattern (32) , which leads to the question of the direction of the enzyme movement during the degradation of the HA substrate chain. Several lines of structural evidence suggest that this processive degradation of the HA substrate chain is accomplished from the reducing end to the nonreducing end. First, the catalytic residues of the enzyme are located at the reducing end of the bound HA2 substrate-like molecules, a disaccharide product. The structural arrangement of the catalytic residues provides the enzyme with the ability to cleave the substrate chain at the reducing end of the ␤-1,4 glycosidic linkage and the product unsaturation happens at the nonreducing end glucuronate C4-C5 of the HA1 disaccharide unit. Second, the negative patch, composed of Glu 468 , Asp 478 , and Thr 480 , is located at the ␤II-domain side of the HA1 position, opposite to Phe 423 in the cleft (Fig. 6 ). This negative patch repels the negatively charged product, HA1, out of the cleft while the HA2 end of the chain (which corresponds to the nonreducing end of the substrate chain) is still bound to the cleft. Third, the product release allows the HA1 position in the cleft to accept another disaccharide unit of the substrate chain. The Phe 423 residue guides the substrate chain into the emptied HA1 position before the long HA chain leaves the cleft. In this way, the disaccharide unit at the HA2 position moves into the HA1 position and HA3 moves into HA2. The disaccharide unit next to HA3 at the nonreducing end of the HA chain moves into the HA3 position. Therefore, the HA chain is degraded in the way that the HA substrate chain moves from reducing end successively to the nonreducing end. As a comparison, the cellulose degradation by cellobiohydrolase I is also performed in a processive pattern and the polysaccharide chain is degraded from the reducing end to the nonreducing end (33) .
At this time, the molecular directionality of polymerization of vertebrate and streptococcal HA is unclear. Early reports suggested that the streptococcal HA is elongated at the nonreducing end extrudes through the plasma membrane into the pericellular space (34) .
Degradation of CS-CS is another substrate of SagHL (35) . Both HA and CS are members of a large polysaccharide family known as glycosaminoglycans. Glycosaminoglycans are a group of heterogeneous polysaccharides built of repeating disaccharide units and contribute to the complex architecture of the extracellular matrix. The disaccharide unit employed to build CS is constructed by ␤-1,3-linked glucuronate and galactosamine. The glycosidic linkage between disaccharide units is ␤-1,4. CS is usually 4-and/or 6-sulfated on the N-acetylgalactosamine residue (35) . The product unsaturation also occurs on the glucuronate residues of the CS chain in the lyase degradation process. When chondroitin molecules were modeled into the cleft of the SagHL structure (data not shown), the same group of catalytic residues targeted very well for the CS degradation. The unsulfated regions of CS can be degraded the same way through the degradation mechanism as shown earlier for HA. For the sulfated CS regions, the HA1 4-sulfated galactosamine is in conflict with Phe 423 . Therefore, SagHL likely can not degrade 4-sulfated CS. The 6-sulfated CS at the HA1 and other positions is not in conflicts with Phe 423 or any other enzyme residues. It can be expected from this structure analysis that, in the CS degradation by SagHL, only unsulfated or 6-sulfated can be degraded. This analysis is supported by the biochemical studies showing that, among the products of SagHL degradation of CS, only unsulfated or 6-sulfated galactosamine were detected (35) .
Structural Comparison to S. pneumoniae Hyaluronate Lyase-The crystal structure of SpnHL has recently been de- FIG. 7 . Sequence alignment of a segment of six bacterial lyases. Sequence alignment was performed on regions containing the catalytic residues of Sag_HL3502 (S. agalactiae hyaluronate lyase from strain 3502; SwissProt code Q53591), Sag_HL4755 (S. agalactiae hyaluronate lyase from strain 4755; SwissProt code Q86478), Spn_HL (S. pneumoniae hyaluronate lyase; SwissProt code Q54873), Sco_SL (Streptomyces coelicolor A3 putative lyase; SwissProt code Q86516), Pal_XLA (Paenibacillus alginolyticus XL-1 pyruvated mannose-specific xanthan lyase; GenBank code AF242413), and Fhe_CL (Flavobacterium heparinum chondroitin AC lyase; SwissProt code Q59288). Catalytic residues were marked using #, aromatic patch residues using *, and negative patch residues using ϩ. Sequence alignment was performed using Multi-align (42) and displayed by MPSA (43) . The color coding for the alignment is as follows: red, single fully conserved residue; green, either strong or weaker groups that are fully conserved; blue, nothing in particular.
termined (12) . The SagHL structure is similar to that of SpnHL in the whole structure architecture and the active site geometry except the ␤I-domain, which is missing. The ␣-domain, the linker II, and the ␤II-domain in SagHL are present in SpnHL. The root mean square deviation of the C ␣ positions for the whole structures is 2.47 Å. The major difference between these two enzymes is at the larger end of the barrel structure (the part that includes the catalytic cleft) is significantly wider in the SagHL structure. The ␣-and ␤II-domains are rotated by a small angle around the linker II in the SagHL structure as compared with SpnHL. As a consequence, the cleft in the SagHL structure is about 7.3 Å wider than it is in the SpnHL structure. The separate domains ␣ and ␤II are very similar in their structure. Such structural differences suggest that the domains of the hyaluronate lyase enzymes might undergo a relative movement during enzyme's catalysis. Such behavior could facilitate, for example, better substrate binding or release of the product to make the enzyme very efficient.
In the SagHL sequence, there are six sequence insertions (20 residues) and no deletion as compared with the SpnHL enzyme. Five of the insertions are present in the ␤II-domain surface loop areas, which causes greater participation of this domain in the cleft composition. All of these insertions in the structure occurred at the molecular surface, and five of six insertions accumulate around the cleft region, but none is directly related to catalysis or the substrate binding. These insertions are likely related to the differences in the pathogenicity of these two enzymes.
The catalytic residues are conserved between these two enzymes (Fig. 7) . In SpnHL, the catalytic residues are His 399 , Tyr 408 , and Asn 349 . Site-directed mutagenesis and enzymatic activity measurement on the SpnHL enzyme had shown that mutations Y408F, H399A, and N349A eliminate the enzyme activity of SpnHL, similar to the mutation studies performed on SagHL (26) .
Conclusions-HA plays an important role in the construction of the extracellular matrix of virtually all animal tissues. In humans, HA metabolism is a very fast process as compared with the metabolism of other polysaccharides (36) . One third of HA in a human body is overturned every day (37) . The pathogenic strains of S. agalactiae that cause meningitis and septicemia and other serious diseases in humans, especially neonates, usually secrete more hyaluronate lyase to degrade HA and CS, two major kinds of polysaccharide components of the extracellular matrix (5) . Mammals use endogenous hyaluronidases, a group of hydrolases, to accomplish the task of HA degradation. The detailed mechanism of this degradative process is still largely unknown, partly because of the lack of structural knowledge about this group of enzymes but it is very different in principle. The significant difference in the enzymatic action mechanism between these two groups of enzymes degrading hyaluronan makes SagHL a potential target for design of drug against this pathogen. Such drugs would likely not influence the normal fast HA metabolism in humans. As we further our understanding of the pathogenesis of GBS infections, we provide the structural background for the development of novel prophylactic and therapeutic strategies against S. agalactiae-related diseases.
The PAD degradation mechanism proposed for SagHL is also likely relevant to other bacterial polysaccharide lyases. In the crystal structure of chondroitin AC lyase (38) , the ␣-domain, ␤II-domain, and the cleft structure are present and superimpose well on the SagHL structure. The three catalytic residues for the PAD degradation were also identified in the corresponding positions in the chondroitin AC lyase crystal structure (28, 38) (Fig. 8) . The phenylalanine residue in the aromatic patch is not present in the chondroitin AC lyase. This might allow this enzyme to degrade CS with all sulfation patterns because the structural conflict between 4-sulfated CS and the enzyme was eliminated.
The catalytic mechanism established for SagHL also helps to predict the catalytic residues for newly sequenced enzymes. For example, xanthan lyase sequence was recently released (classified as a family 8 member of polysaccharide lyases similarly to SagHL) (39) . Sequence alignment revealed that all catalytic and the aromatic patch residues identified for SagHL are also present in the xanthan lyase sequence. Therefore, it can be anticipated that the catalytic center in xanthan lyase is likely to be composed by Asn 206 , His 256 , and Tyr 265 and the aromatic patch is likely participated in the cleavage sites selection on the xanthan substrate chain. Xanthan lyase is likely to utilize similar PAD degradation mechanism for the xanthan degradation. FIG. 8 . Superposition of the active center of SagHL, SpnHL, and chondroitin AC lyase. The active center residues from SagHL are colored in green, residues from SpnHL in red, and residues from chondroitin AC lyase in yellow. The figure was drawn with Ribbons (40) .
